29 September 2021
Response to speculation
Green Cross Health refers to speculation in the Australian media about its participation in a process to acquire Tamaki Health. Green Cross Health advises that it is working with Pacific Equity Partners (PEP) in that process, as the media speculates. The process is in its early stages.
The nature and terms of any transaction for the acquisition of Tamaki Health have yet to be determined. There is no certainty that Green Cross Health will be the successful party or that any transaction will be concluded.
Green Cross Health confirms it is in compliance with its continuous disclosure obligations.
ENDS
Contact:
Rachael Newfield
[email protected]
Ben Doshi
[email protected]
Analysts nudge up their 12-month target price for A2 to $7.85 from $7.80.
The average spend during the beta launch has been about $1,000.
The board says there is no better offer on the table than the one from Florenz.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details